HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive role of laboratory and clinical treatment response parameters and glucose-6-phosphate dehydrogenase status in the therapy of falciparum malaria.

Abstract
Beyond the criteria of success or failure, the treatment response in malaria may be characterized by a number of clinical parameters such as fever and parasite clearance. These factors are influenced by various biochemical and haematological factors and the parasite's drug response. The aim of the study was the determination of the value of treatment response parameters and their relation to laboratory findings in the treatment of falciparum malaria, irrespective of the severity of disease and the treatment used. The study was conducted at the Hospital for Tropical Diseases in Bangkok with 119 inpatients suffering from falciparum malaria. The median fever (FCT), parasite (PCT) and symptom (SCT) clearance times were 29.75, 43.00 and 48.00 hours respectively. Fever clearance was found to be closely associated with the other two response parameters as well as with the parasite count on admission (P < 0.001), which was therefore found to be a good predictor for the expected duration of the clinical disease. Another important predictor for the persistence of fever may be the glucose-6-phosphate dehydrogenase (G6PD) status of the patients. Individuals with normal G6PD-values had almost double the FCT as compared to those with G6PD-deficiencies (46.5 versus 27.2 hrs), an indication of a protective role conferred by low G6PD-levels. A positive association between red blood cell count and FCT (P = 0.009), may be attributed to a similar protection mediated by anaemia. A possible explanation could lie in the high frequency of haemoglobinopathies in Southeast Asia and their relation to malaria. No comparable associations were noted for PCT and SCT. Particularly the fever clearance was therefore found to be a good indicator of treatment response. Several parasitological and haematological parameters, such as G6PD level and parasitaemia, were identified as reliable predictors of the expected duration of clinical disease in malaria.
AuthorsHarald Noedl, Walther H Wernsdorfer, Srivicha Krudsood, Polrat Wilairatana, Gerhard Wiedermann, Herwig Kollaritsch, Sornchai Looareesuwan
JournalWiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 114 Issue 4 Pg. 158-63 (Feb 28 2002) ISSN: 0043-5325 [Print] Austria
PMID12060982 (Publication Type: Journal Article)
Chemical References
  • Antimalarials
  • Glucosephosphate Dehydrogenase
Topics
  • Adult
  • Antimalarials (therapeutic use)
  • Female
  • Fever (drug therapy)
  • Glucosephosphate Dehydrogenase (blood)
  • Host-Parasite Interactions
  • Humans
  • Liver Function Tests
  • Malaria, Falciparum (diagnosis, drug therapy, enzymology)
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Thailand

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: